Behrens, M Margarita
- Salk Institute for Biological Studies (no department on record)
From the FY2023 NIH awards this investigator leads as contact PI. The department is the award's.
FY2023 NIH rank #105
- Top 1% Funded
- Rising Star
- Program Leader
Researcher identity and coverage
- Current affiliation
- Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
- NIH RePORTER identity
- Profile ID unavailableSearch this ID in NIH RePORTER
- ORCID iD
- No ORCID iD on recordA researcher can add one by claiming this profile.
- ScienceDex PI coverage
- FY2014 through FY2023Career claims are limited to the years shown.Metrics use this researcher's latest loaded PI award year; ScienceDex is current through FY2026.
NIH Funding · FY2023
Linked Award Amount
$17M
Full award amounts, FY2023
Award Records
2
Records listing this PI
Award-Linked Rank
#105
By linked amount among FY2023 PIs
Earliest Year Loaded
2014
ScienceDex PI coverage
Award-linked funding history
Linked NIH award amounts and rank by fiscal year.
FY2023 award records by amount
NIH award records listing Behrens, M Margarita as a PI. Multi-PI records show the full award amount for context.
- 5UM1MH130994-02UM1Contact PICenter for Multiomic Human Brain Cell Atlas$14.1Maward amount
- 5U01AG076805-02U01Contact PICircuit-specific cell types in aging and Alzheimer's disease$2.8Maward amount
Award organization
Organizations that administered FY2023 awards listing Behrens, M Margarita as a PI.
FY2023 award administered by Salk Institute for Biological Studies (CA).
Coverage and award-record milestones
Computed from the fiscal years currently available in ScienceDex.
- 2014First NIH AwardSalk Institute for Biological Studies
- 2014$500K Cumulative Funding
- 2014$1M Cumulative Funding
- 2014Entered Top 50% NationallyRanked #5534
- 2015$2M Cumulative Funding
- 2019$5M Cumulative Funding
- 2019Entered Top 25% NationallyRanked #3631
- 2019Program/Center Grant Leader
- 2021$10M Cumulative Funding
- 2021Entered Top 10% NationallyRanked #706
- 2021Entered Top 5% NationallyRanked #706
- 2022$25M Cumulative Funding
- 2022Entered Top 1% NationallyRanked #51
- 2023$50M Cumulative Funding